Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
WuXi Biologics
WuXi Biologics
Activities:
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
G-CON launches "floorlessPOD" prefabricated cleanroom
The global cleanroom provider has launched its newest innovative prefabricated cleanroom structure that comes without an integrated floor
Thermo Fisher Scientific opens sterile drug facility in Asia
The global company has built a new manufacturing facility and expanded capabilities in Singapore to enable the country’s science and technology sector to accelerate research,...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Pharmaceutical
WuXi Biologics plans to build a comprehensive CRDMO centre in Singapore
This investment will establish a cutting-edge, fully integrated CRDMO centre in Singapore and strenghten WuXi Biologics’ global research, development and manufacturing network
Design & Build
WuXi Biologics closes deal to build biomanufacturing hub in the US
China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in Worcester, US
Design & Build
WuXi completes weather-tight seal of Irish biologics facility
WuXi Biologics has completed the seal of its first global supply facility in Europe that began construction in February 2019
Design & Build
WuXi invests $240m in Irish CDMO operations
WuXi Vaccines, a subsidiary of China-based WuXi Biologics, will spend $240m to build a dedicated vaccine manufacturing facility
Design & Build
WBDC demolishes hospital for WuXi potential biomanufacturing centre
Worcester Business Development Corp has received $15m from the state to demolish the 380,000 sqft section of a vacant hospital in Massachusetts
Manufacturing
WuXi Biologics CEO: Vaccine CDMO is the next area of growth
Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion
Research & Development
Swiss NBE-Therapeutics chooses WuXi Biologics as manufacturing partner
Chinese-Swiss partnership will focus on development and manufacturing capacity of immune-stimulatory ADC treatment against the ROR1 cancer target
Subscribe now